ArticleOncotarget2018
Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.
Fiorella Vanderhoeven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it